Isabella Zinck und Novartis - Info zur Person

(1 - 27 von 56

)

Sandoz launches Phase III clinical trial for biosimilar etanercept

www.firmenpresse.de

Novartis International AG /Sandoz launches Phase III clinical trial for biosimilar etanercept. Processed and transmitted by Thomson Reuters ONE.Th ...

FE Investegate |Novartis International AG Announcements | Novartis ...

www.investegate.co.uk

Edwin Valeriano + Isabella Zinck + om ...

Novartis appoints Jeff George as Division Head, Alcon as Kevin...

www.finanznachrichten.de

NOVARTIS FINANCE S.A. / Novartis appoints Jeff George as Division Head, Alcon as Kevin Buehler retires; Richard Francis named as new Division Head, Sandoz ....

Die Novartis Stiftung lanciert neue Leprastrategie an ihrem Symposium...

www.finanzen.ch

Novartis International AG / Die Novartis Stiftung lanciert neue Leprastrategie an ihrem Symposium über Krankheitseliminierung . Verarbeitet und ...

Novartis announces US renewables agreement to reduce greenhouse gas...

www.prnewswire.com

· Pierre-Michel Bringer + Cory Twining + Thomas Hungerbuehler + Isabella Zinck +

GNW-News: Neues Arzneimittel LCZ696 von Novartis gegen...

www.boerse-online.de

Neues Arzneimittel LCZ696 von Novartis gegen Herzinsuffizienz hat in wegweisender Studie PARADIGM-HF die kardiovaskulär bedingten Todesfälle im Vergleich zu...

Kontakt | Novartis Schweizwww.novartis.ch › investoren › kontakt

www.novartis.com

Team. Samir Shah Global Head Investor Relations Pierre-Michel Bringer Thomas Hungerbuehler Isabella Zinck. Allgemeine Anfragen. Novartis International AG.

NOVARTIS N (NOVN.SW) Interactive Stock Chart - Yahoo Financefinance.yahoo.com › quote › NOVN.SW › chart

finance.yahoo.com

... Central North America Samir Shah+ Sloan Simpson+ Thomas Hungerbuehler Isabella Zinck+ +

Five nonprofit organizations to receive up to $250,000 through...

www.biospace.com

Five nonprofit organizations to receive up to $250,000 through Novartis STEP Program™ to support sickle cell patient initiatives - read this article along with...

NOVARTIS N (NOVN.SW) latest press releases & corporate ...uk.finance.yahoo.com › quote › press-releases

uk.finance.yahoo.com

Pierre-Michel Bringer + Cory Twining + Thomas Hungerbuehler + Isabella Zinck +

Novartis Board of Directors and Dr. Daniel Vasella agree to cancel...

www.businesspress24.com

Novartis International AG /Novartis Board of Directors and Dr. Daniel Vasella agree to cancel the non-compete agreement and all related compensation; Decision...

Novartis announces the appointment of Bruno Strigini as ...

finance.yahoo.com

... + Isabella Zinck, + , ...

Pivotal data for Novartis' investigational compound LDE225 show...

www.benzinga.com

Novartis International AG / Pivotal data for Novartis' investigational compound LDE225 show marked tumor responses in advanced basal cell carcinoma

TR ONE-News: Malaria No More und Novartis starten "Power of One ...

de.finance.yahoo.com

Isabella Zinck + Medienmitteilung (PDF): ...

DJ Thomson Reuters - das-anlegerportal.de

www.das-anlegerportal.de

Isabella Zinck + Edwin Valeriano + Communiqué aux medias (PDF):

Novartis data show early treatment with Mayzent® (siponimod ...novartis.gcs-web.com › Novartis-data-show-early-tr...

novartis.gcs-web.com

· Samir Shah + , Sloan Simpson + Thomas Hungerbuehler + Isabella Zinck +

Novartis Completes Its Fifth Share Repurchase Program - ABN Newswire...

www.abnnewswire.net

Pierre-Michel Bringer Edwin Valeriano + Jason Hannon Thomas Hungerbuehler Richard Jarvis Isabella Zinck

Novartis drug Votubia® receives EU approval to treat ...

www.childneurologyfoundation.org

Samir Shah Pierre-Michel Bringer Thomas Hungerbuehler Isabella Zinck. + + + +

Novartis Foundation Presents Healthcare Models and Disease...

www.csrwire.com

Press Releases get your corporate social responsibility news and information out to journalists, investors, and industry professionals utilizing CSRwire’s...

Novartis to fund five innovative ideas to support patients

www.multivu.com

Central Samir Shah + Pierre-Michel Bringer + Thomas Hungerbuehler + Isabella Zinck +

PRESS RELEASE: World MS Day: - das-anlegerportal.de

www.das-anlegerportal.de

Isabella Zinck + Edwin Valeriano + e-mail: investor.relations@novartis.

Novartis AG, Global Alliance For TB Drug Development Link Up To...

www.biospace.com

Novartis AG, Global Alliance For TB Drug Development Link Up To Search For TB Cure - read this article along with other careers information, tips and advice on...

Novartis AG Holly Springs Facility Becomes First US Pandemic-Ready...

www.biospace.com

Novartis AG Holly Springs Facility Becomes First US Pandemic-Ready Site Licensed By The FDA To Produce Cell-Culture Influenza Vaccines - read this article...